ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fracture"

  • Abstract Number: 1748 • ACR Convergence 2024

    Fracture Incidence Rates in Persons with Rheumatoid Arthritis by Disease Activity Level

    Rachel Elam1, Emma Kersey2, Jing Li3, Gabriela Schmajuk4 and Laura Carbone5, 1Augusta University, Evans, GA, 2University of California San Francisco, San Francisco, CA, 3University of California, San Francisco, San Francisco, CA, 4UCSF / SFVA, San Francisco, CA, 5Augusta University, Augusta, GA

    Background/Purpose: Fracture incidence rates (IRs) are higher in men and women with rheumatoid arthritis (RA) than those without RA, especially for those with higher RA…
  • Abstract Number: 2226 • ACR Convergence 2024

    Site-specific Differences in the Association of Non-vertebral Major Osteoporotic Fractures and Rheumatoid Arthritis

    John Chen1, Malini Chandra2, Laura Carbone3, John Schousboe4, Elisha Garcia2 and Joan Lo2, 1Kaiser Permanente Oakland Medical Center, Oakland, CA, 2Kaiser Permanente, Oakland, CA, 3Augusta University, Augusta, GA, 4University of Minnesota, Minneapolis, MN

    Background/Purpose: Rheumatoid arthritis (RA) and osteoporosis are both chronic, potentially debilitating conditions that frequently co-occur, affecting millions of people annually. Among those with osteoporosis, RA…
  • Abstract Number: 2115 • ACR Convergence 2024

    Clinical Impact of Acute Symptomatic Vertebral Fractures in the United States: An Observational Study

    Neil Binkley1, Michele McDermott2, Eric Yeh2, Joseph Lane3, Jolenta Cheung4, Mona Amet4 and Felicia Cosman5, 1University of Wisconsin, Madison, 2Amgen Inc., Thousand Oaks, 3Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 4Adelphi Real World, Bollington, United Kingdom, 5Columbia University, College of Physicians and Surgeons, New York, NY

    Background/Purpose: To characterize pain status (frequency, severity, persistency) and effect on activities of daily living (ADLs) in patients with symptomatic vertebral fractures (VF).Methods: This was…
  • Abstract Number: 2568 • ACR Convergence 2024

    Incidence of First Fracture in RA Is Increasing Faster Than the General Population

    Owen Taylor-Williams1, Charles Inderjeeth2 and Johannes Nossent3, 1University of Western Australia, Perth, Western Australia, Australia, 2SCGH and OPH Group & University of Western Australia, Perth, Western Australia, Australia, 3University of Western Australia, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia

    Background/Purpose: We aim to better understand osteoporotic fracture epidemiology in rheumatoid arthritis (RA) in a West Australian (WA) RA population. We hypothesized increased availability of…
  • Abstract Number: 2120 • ACR Convergence 2024

    EvaluationofBone Mineral Densityand Trabecular Bone Score in JuvenileSystemicLupusErythematosusPatientsUsing Dual-Energy X-rayAbsorptiometry

    BEATRIZ ROSA1, Melissa Fraga1, Erica Barbosa1, Jade Dib Fernandez2, Marcelo Pinheiro3 and Maria Teresa Terreri4, 1Universidade Federal de São Paulo, São Paulo, SP, Brazil, 2UNIFESP-EPM, São Paulo, SP, Brazil, 3UNIFESP/ EPM, São Paulo, SP, Brazil, 4UNIFESP, São Paulo, SP, Brazil

    Background/Purpose: Juvenile Systemic Lupus Erythematosus (jSLE) is a multisystem inflammatory disease associated with bone mass loss. This loss can be evaluated by using the bone…
  • Abstract Number: 2121 • ACR Convergence 2024

    Increased Fracture Rates in Patients Continuing Methotrexate After Methotrexate-associated Lower Limb Insufficiency Fractures: A Retrospective Follow-up Study

    Roba Ghossan1, OLIVIER FOGEL2, Christian Roux1 and Karine Briot1, 1COCHIN HOSPITAL, PARIS, France, 2AP-HP, Paris, France

    Background/Purpose: Spontaneous  lower limb insufficiency fractures (LLIF) described under prolonged exposure to low-dose methotrexate are often bilateral, multiple, and recurrent. They share a common pathognomonic…
  • Abstract Number: 2125 • ACR Convergence 2024

    Strengthening Fracture Risk Prediction in Rheumatoid Arthritis: Integrating a Self-report Sarcopenia Screening Tool (SARC-F) and Fracture Risk Assessment Tool (FRAX) Scores

    Ana Rodriguez-Flores1, Ana Cecilia Bardan-Inchaustegui2, Mara Ponce2, Galilea Rodriguez3, Anahí Carrazco Chapa4, Valeria Monserrat De Hoyos-Perez5, Gilberto J Cervantes Charles5, Alma Damian Peñaloza5, Cinthia Maribel Cortez Lopez5, CASSANDRA SKINNER TAYLOR6, Roberto Negrete Lopez5, Jesus Cardenas-de la Garza2 and Dionicio Galarza-Delgado7, 1Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 2Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 3Hospital Universitario "Dr Jose Eleuterio Gonzalez", Monterrey, Mexico, 4Hospital Universitario Jose Eleuterio Gonzalez, UANL, Rheumatology, Monterrey, Mexico, Monterrey, Mexico, 5Hospital Universitario Dr José Eleuterio González, Monterrey, Nuevo León, Mexico, 6HOSPITAL UNIVERSITARIO DR JOSE ELEUTERIO GONZALEZ, MONTERREY, Mexico, 7UANL Hospital Universitario, Monterrey, Nuevo León, Mexico

    Background/Purpose: Rheumatoid arthritis (RA) patients have an increased risk of fractures due to factors such as chronic inflammation, use of glucocorticoids, and reduced muscle mass.…
  • Abstract Number: 2128 • ACR Convergence 2024

    Trabecular Bone Score Curve from a Qatari Population, Data from Qatar Biobank

    Omar Alsaed1, Hans Didier2 and Samar Alemadi3, 1Hamad Medical Corporation, Doha, Qatar, 2Lausanne University Hospital, Lausanne, Switzerland, 3Hamad medical corporation, Doha, Qatar

    Background/Purpose: Trabecular bone score (TBS iNsight™) is an advanced imaging software application for bone densitometers (DXA). TBS gives an assessment of bone architecture by estimating…
  • Abstract Number: 2013 • ACR Convergence 2023

    Clinical Characteristics and Risk Factors Associated with Fragility Fractures in Patients with Primary and Idiopathic Mast Cell Activation Syndromes

    Ana Isabel Ramos Lisbona1, Karen Carpio Astudillo1, Filip Skrabski1, Alicia Prieto García1, Isabel Castrejon1, Javier Rivera2, José María Álvaro-Gracia1 and Teresa González1, 1Hospital General Universitario Gregorio Marañón, Madrid, Spain, 2Hospital General Universitario Gregorio Marañon, Madrid, Spain

    Background/Purpose: Mast Cell Activation Syndromes (MCAS) are a group of disorders presenting with episodic multisystem symptoms, predominantly anaphylaxis, as the result of mast cell mediator…
  • Abstract Number: 2123 • ACR Convergence 2023

    Dose Trabecular Bone Score (TBS) Add Predictive Value to Fracture Risk Assessment (FRAX) in Rheumatoid Arthritis?

    Jia-Feng Chen1, Tien-Tsai Cheng2 and Hong-Yo Kang3, 1Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan, 2Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, College of Medicine, Kaohsiung, Taiwan, 3Graduate Institute of Clinical Medical Sciences, Chang Gung University, College of Medicine, Kaohsiung, Taiwan

    Background/Purpose: Trabecular bone score (TBS) of lumbar spine is a dual X-ray densitometry (DXA)-based tool to evaluate bone microarchitecture, providing information on bone quality in…
  • Abstract Number: 2138 • ACR Convergence 2023

    Frailty Is a Predictor of Incident Osteoporotic Fractures in Veterans with Rheumatoid Arthritis

    K Wysham1, Hannah Brubeck2, Aaron Baraff3, Punyasha Roul4, Namrata Singh5, James Andrews6, Grant Cannon7, Gary Kunkel8, Ted R Mikuls9, Bryant England4, Dolores Shoback10, Patti Katz11, Jose Garcia12, Ariela Orkaby13 and Joshua Baker14, 1VA Puget Sound/University of Washington, Seattle, WA, 2VA Puget Sound Health Care System, Seattle, WA, 3VA Puget Sound Seattle, Seattle, WA, 4University of Nebraska Medical Center, Omaha, NE, 5University of Washington, Bellevue, WA, 6University of Washington, Seattle, WA, 7University of Utah and Salt Lake City VA, Salt Lake City, UT, 8University of Utah, Salt Lake City, UT, 9Division of Rheumatology and Immunology, University of Nebraska Medical Center, Omaha, NE, 10San Francisco VA Medical Center, San Francisco, CA, 11University of California San Francisco, San Rafael, CA, 12VA Puget Sound Healthcare System, Seattle, WA, 13Veterans Affairs Boston Healthcare System & Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; VA Geriatric Research Education and Clinical Center, Boston, MA, 14University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Frailty occurs prematurely in RA. Levels of frailty are higher in Veteran populations than civilians1. Frailty has been shown to predict osteoporotic fractures in…
  • Abstract Number: 2429 • ACR Convergence 2023

    Romosozumab versus Denosumab in High-risk Patients Treated with Glucocorticoids: Interim 12-month Results from a Pilot Randomized Controlled Trial

    Chi Chiu Mok1, SAU MEI TSE2, Kar Li Kelly Chan3 and Wai Han Ma1, 1Tuen Mun Hospital, Hong Kong, Hong Kong, 2Tuen Mun Hospital, Hong Kong, China, 3Tuen Mun Hospital, Shatin, China

    Background/Purpose: To compare the efficacy and safety of romozosumab (ROMO) and denosumab (DEN) in high-risk patients treated with glucocorticoids (GCs). Methods: Adult patients (≥18 years)…
  • Abstract Number: 2528 • ACR Convergence 2023

    Current Trends in the Risk of Subsequent Fracture After Initial Fracture, and Post-Fracture Treatment Among Commercially Insured Postmenopausal Women in the United States

    Min Kim1, Vanessa C. Brunetti1, Felicia Cosman2, Jeffrey Curtis3, E Michael Lewiecki4, Matthew Phelan5, Peter Samai5, Michele McDermott1, Tzu-Chieh Lin1, M Alan Brookhart6 and Kathleen Hurwitz5, 1Amgen, Inc., Thousand Oaks, CA, 2Columbia University, New York, NY, 3University of Alabama at Birmingham, Birmingham, AL, 4New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, 5Target RWE, Durham, NC, 6Department of Population Health Sciences, Duke University, Durham, NC

    Background/Purpose: Recent studies suggest that post-fracture pharmacologic management has been declining in the U.S. despite an increase in the burden of osteoporosis (OP). In light…
  • Abstract Number: 0167 • ACR Convergence 2023

    Healthcare Resource Utilization Associated with Tumor-Induced Osteomalacia: Review of Patient Histories Prior to Entry in Clinical Trial UX023T-CL201

    Suzanne Jan de Beur1, Thomas Carpenter2, Kathryn Dahir3, Erik Imel4, María Belén Zanchetta5, Angela Williams6, Zhiyi Li7, Matthew Sharp6 and Ben Johnson6, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Yale School of Medicine, New Haven, CT, 3Vanderbilt University Medical Center, Nashville, TN, 4Indiana University School of Medicine, Indianapolis, IN, 5Universidad del Salvador, Buenos Aires, Argentina, 6Kyowa Kirin International, Marlow, United Kingdom, 7Kyowa Kirin North America, Bedminster, NJ

    Background/Purpose: Tumor-induced osteomalacia (TIO) is an ultra-rare paraneoplastic disorder, characterized by renal phosphate wasting due to increased production of fibroblast growth factor 23 (FGF23). Chronic…
  • Abstract Number: 0235 • ACR Convergence 2023

    Fractures in Patients with Acute CPP Crystal Arthritis versus Matched Comparators in a Large Cohort Study

    Sara Tedeschi1, Keigo Hayashi1, Ann Rosenthal2, Javier Marrugo1, Sho Fukui1, Ellen Gravallese3 and Daniel Solomon1, 1Brigham and Women's Hospital, Boston, MA, 2Medical College of Wisconsin, Milwaukee, WI, 3Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Calcium pyrophosphate deposition (CPPD) disease was positively associated with osteopenia in two large cross-sectional studies, but risk of fractures has not been evaluated. We…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 7
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology